AR009338A1 - Composicion de dosis de unidad multivitaminica y usos de dicha composicion de dosis - Google Patents

Composicion de dosis de unidad multivitaminica y usos de dicha composicion de dosis

Info

Publication number: AR009338A1
Authority: AR; Argentina
Prior art keywords: vitamin; dose composition; unit dose; multivitaminic; composition
Prior art date: 1996-08-26

Application number

Other languages

English (en)

Spanish (es)

Original Assignee

Gonzalez Nicholas James

Isaacs Linda Lee

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-26

Filing date

1997-08-26

Publication date

2000-04-12

1997-08-26 Application filed by Gonzalez Nicholas James, Isaacs Linda Lee filed Critical Gonzalez Nicholas James

2000-04-12 Publication of AR009338A1 publication Critical patent/AR009338A1/es

Links

YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 abstract 2
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract 1
GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 abstract 1
AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 1
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 abstract 1
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract 1
DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract 1
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract 1
FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract 1
229930003451 Vitamin B1 Natural products 0.000 abstract 1
229930003779 Vitamin B12 Natural products 0.000 abstract 1
229930003471 Vitamin B2 Natural products 0.000 abstract 1
229930003571 Vitamin B5 Natural products 0.000 abstract 1
229930003268 Vitamin C Natural products 0.000 abstract 1
229930003316 Vitamin D Natural products 0.000 abstract 1
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
229930003427 Vitamin E Natural products 0.000 abstract 1
229930003448 Vitamin K Natural products 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 abstract 1
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract 1
235000013734 beta-carotene Nutrition 0.000 abstract 1
TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 abstract 1
239000011648 beta-carotene Substances 0.000 abstract 1
229960002747 betacarotene Drugs 0.000 abstract 1
229960002685 biotin Drugs 0.000 abstract 1
235000020958 biotin Nutrition 0.000 abstract 1
239000011616 biotin Substances 0.000 abstract 1
FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 abstract 1
229960002079 calcium pantothenate Drugs 0.000 abstract 1
OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 abstract 1
229960001231 choline Drugs 0.000 abstract 1
FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
229960000304 folic acid Drugs 0.000 abstract 1
235000019152 folic acid Nutrition 0.000 abstract 1
239000011724 folic acid Substances 0.000 abstract 1
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
229960000367 inositol Drugs 0.000 abstract 1
CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
229960003966 nicotinamide Drugs 0.000 abstract 1
235000005152 nicotinamide Nutrition 0.000 abstract 1
239000011570 nicotinamide Substances 0.000 abstract 1
229960003512 nicotinic acid Drugs 0.000 abstract 1
235000001968 nicotinic acid Nutrition 0.000 abstract 1
239000011664 nicotinic acid Substances 0.000 abstract 1
SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract 1
RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
229960002477 riboflavin Drugs 0.000 abstract 1
CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 abstract 1
229960003495 thiamine Drugs 0.000 abstract 1
DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract 1
229940088594 vitamin Drugs 0.000 abstract 1
229930003231 vitamin Natural products 0.000 abstract 1
235000013343 vitamin Nutrition 0.000 abstract 1
239000011782 vitamin Substances 0.000 abstract 1
235000019155 vitamin A Nutrition 0.000 abstract 1
239000011719 vitamin A Substances 0.000 abstract 1
235000010374 vitamin B1 Nutrition 0.000 abstract 1
239000011691 vitamin B1 Substances 0.000 abstract 1
235000019163 vitamin B12 Nutrition 0.000 abstract 1
239000011715 vitamin B12 Substances 0.000 abstract 1
235000019164 vitamin B2 Nutrition 0.000 abstract 1
239000011716 vitamin B2 Substances 0.000 abstract 1
235000009492 vitamin B5 Nutrition 0.000 abstract 1
239000011675 vitamin B5 Substances 0.000 abstract 1
235000019158 vitamin B6 Nutrition 0.000 abstract 1
239000011726 vitamin B6 Substances 0.000 abstract 1
235000019154 vitamin C Nutrition 0.000 abstract 1
239000011718 vitamin C Substances 0.000 abstract 1
235000019166 vitamin D Nutrition 0.000 abstract 1
239000011710 vitamin D Substances 0.000 abstract 1
150000003710 vitamin D derivatives Chemical class 0.000 abstract 1
235000019165 vitamin E Nutrition 0.000 abstract 1
239000011709 vitamin E Substances 0.000 abstract 1
229940046009 vitamin E Drugs 0.000 abstract 1
235000019168 vitamin K Nutrition 0.000 abstract 1
239000011712 vitamin K Substances 0.000 abstract 1
150000003721 vitamin K derivatives Chemical class 0.000 abstract 1
229940045997 vitamin a Drugs 0.000 abstract 1
229940011671 vitamin b6 Drugs 0.000 abstract 1
229940046008 vitamin d Drugs 0.000 abstract 1
229940046010 vitamin k Drugs 0.000 abstract 1
OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

ARP970103874 1996-08-26 1997-08-26 Composicion de dosis de unidad multivitaminica y usos de dicha composicion de dosis AR009338A1 (es)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US70330196A	1996-08-26	1996-08-26
US74455096A	1996-11-06	1996-11-06
US83336597A	1997-04-04	1997-04-04

Publications (1)

Publication Number	Publication Date
AR009338A1 true AR009338A1 (es)	2000-04-12

Family

ID=27418756

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ARP970103874 AR009338A1 (es)	1996-08-26	1997-08-26	Composicion de dosis de unidad multivitaminica y usos de dicha composicion de dosis

Country Status (6)

Country	Link
AR (1)	AR009338A1 (fr)
AU (1)	AU4162297A (fr)
CO (1)	CO4900029A1 (fr)
ID (1)	ID19355A (fr)
MA (1)	MA24308A1 (fr)
WO (1)	WO1998008522A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2130533A4 (fr) *	2007-04-05	2010-04-21	J Oil Mills Inc	Agent neuroleptique et aliment fonctionnel
CN104027339B (zh) *	2014-06-12	2017-01-18	王淑芳	一种维生素组合物及其调理卵巢功能应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4432975A (en) *	1981-04-13	1984-02-21	Icn Pharmaceuticals, Inc.	Process for introducing vitamin B-12 into the bloodstream
US4945083A (en) *	1986-06-03	1990-07-31	Jansen Jr Christian J	Safe oral folic-acid-containing vitamin preparation
US5308627A (en) *	1990-08-07	1994-05-03	Umbdenstock Jr Anthony J	Nutritional supplement for optimizing cellular health
US5514382A (en) *	1994-10-17	1996-05-07	Sultenfuss; Sherry	Daily vitamin and mineral supplement for women

1997
- 1997-08-25 CO CO97048862A patent/CO4900029A1/es unknown
- 1997-08-26 ID IDP972975A patent/ID19355A/id unknown
- 1997-08-26 AU AU41622/97A patent/AU4162297A/en not_active Abandoned
- 1997-08-26 WO PCT/US1997/014968 patent/WO1998008522A1/fr not_active Ceased
- 1997-08-26 MA MA24777A patent/MA24308A1/fr unknown
- 1997-08-26 AR ARP970103874 patent/AR009338A1/es unknown

Also Published As

Publication number	Publication date
AU4162297A (en)	1998-03-19
CO4900029A1 (es)	2000-03-27
ID19355A (id)	1998-07-02
WO1998008522A1 (fr)	1998-03-05
MA24308A1 (fr)	1998-04-01

Similar Documents

Publication	Publication Date	Title
US5770215A (en)	1998-06-23	Multivitamin/vascular occlusion inhibiting composition
DE69332777D1 (de)	2003-04-24	Multivitamin- und mineralstoffergänzung für schwangere
ES2269514T5 (es)	2015-04-01	Compuesto nutritivo para tratar afecciones inmunológicas
AR004108A1 (es)	1998-09-30	Uso del 4-(4-fluorobencilamino)-2-amino-1-etoxicarbonilaminobenceno y sus sales farmaceuticamente aceptables para la preparacion de un medicamento destinado a la profilaxis y el tratamiento de las consecuencias de la insuficiencia aguda y crónica de la irrigacion sanguinea cerebral y el tratamiento de las enfermedades neurodegenrativas
Russell	1997	New views on the RDAs for older adults
AR008878A1 (es)	2000-02-23	Antagonistas del receptor de vitronectina, un metodo para su preparacion, una composicion farmaceutica que los contiene y el uso de las mismas para la preparacion de un medicamento.
BR0114080A (pt)	2003-07-29	Suplemento alimentìcio, uso do mesmo, método para auxiliar a prevenção ou tratamento de dano oxidativo, alimento, e, métodos para fabricar o mesmo, e para melhorar ou aumentar a produção de trabalho de um animal
MX9301787A (es)	1994-02-28	Producto nutricional liquido para alimentacion enteral.
NZ516101A (en)	2003-06-30	Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
CY1112547T1 (el)	2015-12-09	Μεσα που περιεχουν φολικο οξυ, βιταμινη β6 και βιταμινη β12, και η χρηση αυτων
ES2092275T3 (es)	1996-11-16	Producto nutritivo para personas que reciben dialisis renal.
MX9307883A (es)	1994-06-30	Aplicacion del riluzol en la preparcion de un medicamento para el tratamiento de lesiones neurologicas.
US5883086A (en)	1999-03-16	DHEA-containing nutritional supplement
ES2191682T3 (es)	2003-09-16	Nueva formulacion farmaceutica.
MX9307885A (es)	1994-07-29	Aplicacion de la carbamzaepina y oxcarbazepian para la obtencion de medicamentos para el tratamiento de la enfermedad de parkinson y los sindromes parkinsonianos.
MX9203444A (es)	1993-12-01	Medicamentos.
AR042262A2 (es)	2005-06-15	Uso de 8,9-dihidroestrona para la preparacion de un medicamento para el tratamiento de aterosclerosis
ATE198835T1 (de)	2001-02-15	Knochenwachstumsfördernde zusammensetzung
BR9609413A (pt)	1999-05-18	Formulações de dieta e farmacêuticas para a profilaxia e o tratamento de distúrbios gastrintestinais
AR123714A1 (es)	2023-01-04	Biofactores para el tratamiento y la profilaxis de la demencia
WO1995031991A3 (fr)	1996-02-15	Utilisation de produits a base de magnesium pour le traitement ou la prophylaxie de maladies neoplasiques et auto-immunes
AR039633A2 (es)	2005-03-02	Uso de un compuesto tipo cabergolina para preparar un medicamento para el tratamiento de la fibromialgia y el sindrome de fatiga cronica
ES2105219T3 (es)	1997-10-16	Una composicion que contiene hierro para la prevencion de la anemia y un metodo para producir dicha composicion.
ES2149279T3 (es)	2000-11-01	Sistema terapeutico para el tratamiento de la psoriasis.
AR026254A1 (es)	2003-02-05	El uso de una preparacion de liberacion controlada para la preparacion de un medicamento para aumentar la dosis o la exposicion sistemica de un farmaco queinhibe la fosfodiesterasa 4